These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 15261941

  • 21. The origin of P-selectin as a circulating plasma protein.
    Fijnheer R, Frijns CJ, Korteweg J, Rommes H, Peters JH, Sixma JJ, Nieuwenhuis HK.
    Thromb Haemost; 1997 Jun; 77(6):1081-5. PubMed ID: 9241736
    [Abstract] [Full Text] [Related]

  • 22. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT, Tayebjee MH, Lim HS, Lip GY.
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [Abstract] [Full Text] [Related]

  • 23. Plasma beta-thromboglobulin to platelet factor 4 ratios as indices of vascular complications in essential hypertension.
    Gomi T, Ikeda T, Yuhara M, Sakurai J, Nakayama D, Ikegami F.
    J Hypertens; 1988 May; 6(5):389-92. PubMed ID: 2968397
    [Abstract] [Full Text] [Related]

  • 24. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4.
    Panasiuk A, Prokopowicz D, Zak J, Matowicka-Karna J, Osada J, Wysocka J.
    Hepatogastroenterology; 2001 May; 48(39):818-22. PubMed ID: 11462931
    [Abstract] [Full Text] [Related]

  • 25. Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension?
    Muxfeldt ES, Salles GF.
    J Hypertens; 2008 May; 26(5):878-84. PubMed ID: 18398329
    [Abstract] [Full Text] [Related]

  • 26. Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy.
    Nadar S, Blann AD, Lip GY.
    Ann Med; 2004 May; 36(7):552-7. PubMed ID: 15513305
    [Abstract] [Full Text] [Related]

  • 27. Plasma levels of P-selectin are determined by platelet turn-over and the P-selectin Thr715Pro polymorphism.
    Panzer S, Rosales S, Gisslinger H, Jungbauer L, Kaider A, Knöbl P, Sillaber C, Pabinger I.
    Thromb Res; 2008 May; 121(4):573-9. PubMed ID: 17698171
    [Abstract] [Full Text] [Related]

  • 28. Effects of immunosuppressive drugs on platelet aggregation and soluble P-selectin levels in renal transplant patients.
    Sahin G, Akay OM, Kus E, Bal C, Yalcin AU, Gulbas Z.
    Ren Fail; 2009 May; 31(2):111-7. PubMed ID: 19212907
    [Abstract] [Full Text] [Related]

  • 29. Altered megakaryocyte-platelet haemostatic axis in hypercholesterolaemia.
    Pathansali R, Smith N, Bath P.
    Platelets; 2001 Aug; 12(5):292-7. PubMed ID: 11487381
    [Abstract] [Full Text] [Related]

  • 30. Soluble P selectin levels in chronic liver disease: relationship to disease severity.
    Vardareli E, Saricam T, Demirustu C, Gulbas Z.
    Hepatogastroenterology; 2007 Mar; 54(74):466-9. PubMed ID: 17523300
    [Abstract] [Full Text] [Related]

  • 31. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.
    Navarro-González JF, Mora C, Muros M, Jarque A, Herrera H, García J.
    J Hypertens; 2008 Nov; 26(11):2168-75. PubMed ID: 18854757
    [Abstract] [Full Text] [Related]

  • 32. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Tayebjee MH, Nadar S, Blann AD, Gareth Beevers D, MacFadyen RJ, Lip GY.
    Am J Hypertens; 2004 Sep; 17(9):764-9. PubMed ID: 15363817
    [Abstract] [Full Text] [Related]

  • 33. The plasma levels of soluble P-selectin in subjects with prediabetes.
    Dogru T, Tasci I, Sonmez A, Genc H, Gok M, Yilmaz MI, Ural AU, Olgun A, Kilic S, Bozoglu E, Erdem G, Erbil K.
    Int J Clin Pract; 2006 Sep; 60(9):1048-52. PubMed ID: 16939545
    [Abstract] [Full Text] [Related]

  • 34. Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity.
    Chung I, Choudhury A, Patel J, Lip GY.
    J Intern Med; 2008 Mar; 263(3):313-21. PubMed ID: 18086125
    [Abstract] [Full Text] [Related]

  • 35. [Selectins in the pathogenesis and diagnosis of early atherosclerotic changes in children and adolescents with risk factors (obesity, hypertension and diabetes)].
    Głowińska B, Urban M, Peczyńska J, Florys B.
    Przegl Lek; 2004 Mar; 61(9):935-9. PubMed ID: 15803902
    [Abstract] [Full Text] [Related]

  • 36. Does smoking affect thrombocytopoiesis and platelet activation in women and men?
    Butkiewicz AM, Kemona-Chetnik I, Dymicka-Piekarska V, Matowicka-Karna J, Kemona H, Radziwon P.
    Adv Med Sci; 2006 Mar; 51():123-6. PubMed ID: 17357291
    [Abstract] [Full Text] [Related]

  • 37. Cytoplasmic free calcium mobilization in platelets, expression of P-selectin, phosphatidylserine, and microparticle formation, measured by whole blood flow cytometry, in hypertensive patients. Effect of doxazosin GITS.
    Labiós M, Martínez M, Gabriel F, Guiral V, Ruiz-Aja S, Aznar J.
    Thromb Res; 2006 Mar; 117(4):403-9. PubMed ID: 16461073
    [Abstract] [Full Text] [Related]

  • 38. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria.
    Ferroni P, Guagnano MT, Falco A, Paoletti V, Manigrasso MR, Michetti N, Santilli F, Guadagni F, Basili S, Davì G.
    Clin Sci (Lond); 2008 Mar; 114(6):449-55. PubMed ID: 17988217
    [Abstract] [Full Text] [Related]

  • 39. Acute effects of nicotine infusion on platelets in nicotine users with normal and impaired renal function.
    Whiss PA, Lundahl TH, Bengtsson T, Lindahl TL, Lunell E, Larsson R.
    Toxicol Appl Pharmacol; 2000 Mar 01; 163(2):95-104. PubMed ID: 10698667
    [Abstract] [Full Text] [Related]

  • 40. Elevation of serum soluble E- and P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker.
    Sanada H, Midorikawa S, Yatabe J, Yatabe MS, Katoh T, Baba T, Hashimoto S, Watanabe T.
    Hypertens Res; 2005 Nov 01; 28(11):871-8. PubMed ID: 16555575
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.